Radiologists’ Pay Tied to Quality Metrics?
Should quality measures help determine a physician's pay?
Quality measurements are playing a small yet growing role in physician compensation.
Specialists reported that 2 percent of their total compensation was based on quality metrics, according to the recently released Medical Group Management Association (MGMA) Physician Compensation and Production Survey: 2013 Report Based on 2012 Data, which provides data on more than 60,000 providers. Meanwhile, primary-care physicians reported that 3 percent of their total compensation was based on quality. Survey respondents also said patient satisfaction played a small role in their compensation.
This number is sure to grow as healthcare reform encourages new payment models and a move away from fee-for-service. Accountable care organizations, for example, seek to tie reimbursement to quality metrics.
“Quality and patient satisfaction metrics are not yet dominant components of physician compensation plans right now, however, as reimbursement models continue to shift, the small changes we’ve observed recently will gain momentum,” Susan L. Turney, MGMA-ACMPE president and CEO, said in a statement.
Should physician pay be more closely aligned with quality measures? Why or why not?
Share your thoughts in the comments section below.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
